Related Experiment Videos
Nonmelanoma skin cancer mortality. A population-based study
M A Weinstock1, H A Bogaars, M Ashley
1Department of Medicine, Veterans Affairs Medical Center, Providence, RI 02908.
Archives of Dermatology
|August 1, 1991
Summary
Nonmelanoma skin cancer caused 51 deaths in Rhode Island between 1979-1987, primarily squamous cell carcinoma. This study highlights the mortality parameters of nonmelanoma skin cancer, informing prevention and treatment strategies.
Area of Science:
- Dermatology
- Epidemiology
- Public Health
Background:
- Nonmelanoma skin cancer (NMSC) is a significant health concern.
- Understanding NMSC mortality is crucial for public health initiatives.
Purpose of the Study:
- To estimate the mortality rate of NMSC.
- To describe the characteristics of NMSC deaths.
- To inform prevention and treatment strategies for NMSC.
Main Methods:
- Retrospective review of death certificates in Rhode Island (1979-1987).
- Inclusion criteria: deaths certified as due to NMSC.
- Exclusion criteria: acquired immunodeficiency syndrome-associated Kaposi's sarcoma.
Main Results:
- 51 confirmed NMSC deaths, with an age-adjusted mortality rate of 0.44/10^5 per year.
- Squamous cell carcinoma (SCC) accounted for 59% of deaths, basal cell carcinoma (BCC) for 20%.
- SCC deaths had a mean age of 73, with 80% metastasizing and 47% occurring on the ear. BCC deaths had a mean age of 85, with 40% involving refusal of treatment.
Conclusions:
- NMSC mortality is a significant issue, particularly SCC.
- Findings underscore the need for improved prevention, early detection, and treatment of NMSC.
- Further research into risk factors and patient adherence is warranted.